NRx Pharmaceuticals Inc. (NRXP)
NASDAQ: NRXP
· Real-Time Price · USD
2.88
0.21 (7.87%)
At close: Aug 15, 2025, 3:59 PM
2.87
-0.34%
After-hours: Aug 15, 2025, 07:40 PM EDT
NRx Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -24.11M | -25.13M | -20.38M | -24.82M | -25.64M | -30.15M | -36.06M | -39.08M | -37.34M | -39.75M | -60.31M | -72M | -81.02M | -93.06M | -107.4M | -91.79M | -75.78M |
Depreciation & Amortization | 11K | 5K | 5K | 5K | 5K | 5K | 5K | 4K | 4K | 4K | 3.4K | 3.03K | 3K | 2K | 2.5K | 2.97K | 2K |
Stock-Based Compensation | 256K | 486K | -760K | -513K | -66K | 387K | 2.36M | 2.55M | 2.99M | 3.63M | 4.43M | 5.45M | 8.75M | 7.79M | 6.57M | 5.2M | 919.82K |
Other Working Capital | 10.31M | 10.51M | 1.85M | 1.83M | 1.91M | 15K | -644K | 3.22M | -2.75M | 2.31M | 3.3M | 9.1M | -2.87M | -7.44M | -9.72M | -21.41M | -4.48M |
Other Non-Cash Items | 8.53M | 7.01M | -2.34M | -1.25M | -2.53M | 750K | 3.52M | 3.2M | -314K | -4.33M | 14.06M | 22.36M | 30.17M | 53.68M | 74.36M | 66.03M | 60.82M |
Deferred Income Tax | n/a | n/a | 2.2M | 2.18M | 2.19M | 2.19M | -15K | 11K | n/a | n/a | 0.00 | 260.24K | -1.21M | -1.21M | 1.49M | 3.91M | 5.38M |
Change in Working Capital | 3M | 5.29M | 7.8M | 8.57M | 4.96M | 5.16M | 3.41M | 4.84M | -798K | 699K | -908.76K | -4.55M | -1.76M | -4.9M | -1.85M | 694.57K | 4.1M |
Operating Cash Flow | -11.39M | -11.58M | -12.67M | -14.93M | -19.24M | -21.66M | -26.78M | -28.48M | -35.46M | -39.76M | -42.72M | -48.47M | -45.07M | -37.7M | -26.83M | -15.94M | -4.55M |
Capital Expenditures | n/a | n/a | 4K | 2K | 4K | n/a | -3K | -6K | -11K | -10K | -11.39K | -10.22K | -10K | -7K | -8.61K | -4.78K | -2K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 25.96M | 25.96M | 25.96M |
Purchase of Investments | n/a | n/a | -3K | -3K | -3K | -3K | -10K | -10K | -10K | -10K | -7K | -7K | -7K | -7K | 192.52K | 192.52K | 192.52K |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -26.12M | -26.12M | -26.12M |
Other Investing Acitivies | n/a | n/a | -3K | -3K | -3K | -7K | 6K | 6K | 6K | 7K | 29.78K | 29.78K | 29.78K | 32.78K | -33.16K | 272.97K | 249.75K |
Investing Cash Flow | n/a | n/a | 1K | -1K | 1K | -3K | -3K | -6K | -11K | -10K | -11.39K | -10.22K | -10K | -7K | -8.61K | 301.35K | 280.91K |
Debt Repayment | 659K | -1.5M | -3.5M | -5.94M | -5.25M | -3.09M | 8.04M | 10.72M | 10.02M | 10.02M | 474.00 | -176K | -176K | -176K | -186K | 158.00 | 158.00 |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -26.53M | -26.53M | -26.53M |
Other Financial Acitivies | 7.4M | 3.07M | 2.06M | n/a | n/a | n/a | 102K | 102K | -416K | -416K | -518.12K | -518.12K | 9.95M | 17.45M | 17.45M | 17.45M | 7.5M |
Financial Cash Flow | 14.68M | 7.49M | 4.47M | 919K | 4.05M | 6.2M | 17.44M | 18.91M | 11.78M | 32.21M | 22.09M | 59.64M | 72.01M | 63.46M | 64.44M | 28.34M | 16.83M |
Net Cash Flow | 4.23M | -3.15M | -7.26M | -13.07M | -15.19M | -15.46M | -9.35M | -9.58M | -23.7M | -7.55M | -20.63M | 11.16M | 26.93M | 25.75M | 37.6M | 12.39M | 12.28M |
Free Cash Flow | -11.39M | -11.58M | -12.67M | -14.93M | -19.23M | -21.66M | -26.79M | -28.49M | -35.48M | -39.77M | -42.73M | -48.48M | -45.08M | -37.71M | -26.84M | -15.95M | -4.55M |